Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Clinical genetic testing for BRCA1 and BRCA2 has become available in the past 15 years, and it has been established that female BRCA carriers have a high lifetime risk to develop both breast and ovarian cancer. Predisposition testing makes it possible to predict risk in families and to tailor medical management accordingly. In addition to close surveillance, prophylactic mastectomy and oophorectomy are primary risk reduction strategies offered to BRCA carriers. Although the emphasis of research thus far has been on the efficacy of surveillance and risk reduction strategies, it has become clear that genetic testing and the resulting medical decisions around risk reduction lead to a unique set of emotional, physical, and sexual issues for female BRCA carriers and their children. This article will focus on those issues in unaffected female BRCA carriers.
Matloff
Ellen T
ET
Cancer Genetic Counseling, Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. ellen.matloff@yale.edu
Barnett
Rachel E
RE
Bober
Sharon L
SL
D001828:Body Image; D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control / Q000523:psychology; D003657:Decision Making; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D005298:Fertility; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006580:Genetic Carrier Screening; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D007398:Interpersonal Relations; D008393:Marriage; D008408:Mastectomy; D009154:Mutation; D010051:Ovarian Neoplasms / Q000517:prevention & control; D010052:Ovariectomy; D011247:Pregnancy; D046468:Sexual Development; D019529:Sexuality